| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-05-20 | NCT07598955 Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2… | Phase 1/2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07164469 | Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed… | Large B-cell Lymphoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07598955 | Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2… | B2 Thymoma | Recruiting |
| NCT07509008 | Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered… | Gastric Cancer, Metastatic | Not Yet Recruiting |
| Phase 1 | |||
| NCT06066424 | Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord… | Solid Tumors | Recruiting |
| NCT06358430 | Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord… | Colorectal Cancer | Recruiting |
| NCT05239143 | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or… | Breast Cancer | Active, Not Recruiting |
| NCT04960579 | P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma | Multiple Myeloma | Active, Not Recruiting |
| NCT07553390 | Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast… | Breast Cancer | Not Yet Recruiting |
| NCT06014762 | P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell… | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Active, Not Recruiting |
| NCT06984341 | A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and… | Systemic Lupus Erythematosus | Not Yet Recruiting |
| NCT03016377 | Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |